Soleno Therapeutics, Inc. (SLNO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 01:18PM EST. Market open.
| Previous close | 0.9710 |
| Open | 0.9700 |
| Bid | 0.9849 x 2200 |
| Ask | 1.0200 x 1100 |
| Day's range | 0.9700 - 1.0200 |
| 52-week range | 0.9000 - 9.7200 |
| Volume | |
| Avg. volume | 71,568 |
| Market cap | 8.036M |
| Beta (5Y monthly) | 0.31 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Catalyst Pharmaceuticals (CPRX) Rallies 80.69% YTD: Here's Why
Catalyst (CPRX) price rallies on FDA approval of the sNDA of its lead drug, Firdapse, approved to treat LEMS in patients above six years of age.
- Zacks
Catalyst Pharma's (CPRX) sNDA for Firdapse Approved by the FDA
Catalyst Pharmaceuticals (CPRX) announces FDA approval of its sNDA for Firdapse to include pediatric patients for treating Lambert-Eaton myasthenic syndrome.
- Zacks
KemPharm (KMPH) Up On Positive Data From Sleep Disorder Study
KemPharm (KMPH) reports positive top line from a study evaluating serdexmethylphenidate (SDX) for cardiovascular safety to progress the development of its prodrug KP1077.
© 2022 Yahoo. All rights reserved.
